Daniel Reshef is an experienced executive in the pharmaceuticals industry, currently serving as the Executive Director of Oncology at Merck. With a PhD in Epidemiology from Johns Hopkins University and board certification in Ophthalmology, they have demonstrated expertise in Immuno-Oncology, Biomarkers, and Clinical Pharmacology. Daniel's previous roles include Therapeutic Area Lead in Immuno-Oncology at Bristol-Myers Squibb and various leadership positions at Genentech, Takeda, and NIH's National Eye Institute. Renowned for their strong clinical abilities and effective communication skills, Daniel has a proven track record of successful achievements in major healthcare programs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices